antibody drug conjugate
Merck and Daiichi Sankyo expand development and commericalisation agreement to include MK-6070
August 7, 2024Research and Development Daiichi Sankyo, MSD, Merck, Oncology, antibody drug conjugate, neuroendocrine cancer, oncology, small cell lung cancer
Daiichi Sankyo and Merck (known as MSD outside of the US and Canada) have announced the expansion of their co-development …
AstraZeneca to build $1.5bn ADC facility in Singapore
May 20, 2024Manufacturing and Production ADCs, AstraZeneca, Oncology, antibody drug conjugate, manufacturing
AstraZeneca has announced that it intends to build a $1.5bn manufacturing facility in Singapore, Singapore, for antibody drug conjugates (ADCs), …
Sanofi buys into cancer antibody research
January 26, 2011Research and Development Cancer, Oxford Biotherapeutics, Sanofi, Sanofi-Aventis, antibody drug conjugate, cancer research
Sanofi-Aventis has bought a global licence to develop and commercialise one of Oxford BioTherapeutics’ (OBT) oncology programmes. For an undisclosed …
Latest content
AstraZeneca’s Trixeo approved in EU for asthma
October 8, 2026
ESTEVE CDMO adds $17.5m to Illinois expansion
October 6, 2026
